Cargando…
Oxytocin inhibits ovarian cancer metastasis by repressing the expression of MMP-2 and VEGF
Breastfeeding is associated with a decreased risk of ovarian cancer. However, the mechanism underlying this apparent clinical benefit is unknown. Oxytocin (OXT), a hypothalamic nonapetide, plays a crucial role in many reproductive and behavioural functions. In recent year, OXT acts as a growth regul...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929082/ https://www.ncbi.nlm.nih.gov/pubmed/29721047 http://dx.doi.org/10.7150/jca.23769 |
_version_ | 1783319353383452672 |
---|---|
author | Ji, Haoyi Liu, Na Yin, Yingchun Wang, Xinmei Chen, Xiaoyang Li, Jing Li, Jingxin |
author_facet | Ji, Haoyi Liu, Na Yin, Yingchun Wang, Xinmei Chen, Xiaoyang Li, Jing Li, Jingxin |
author_sort | Ji, Haoyi |
collection | PubMed |
description | Breastfeeding is associated with a decreased risk of ovarian cancer. However, the mechanism underlying this apparent clinical benefit is unknown. Oxytocin (OXT), a hypothalamic nonapetide, plays a crucial role in many reproductive and behavioural functions. In recent year, OXT acts as a growth regulator in many kind of tumor tissues, through the activation of a specific G-coupled transmembrane receptor, the oxytocin receptor (OXTR). OXT has been proved to inhibit the proliferation, migration and invasion of ovarian cancer SKOV3 cells in vitro. But, the underlying mechanisms remain unknown. Here, we found OXT inhibited proliferation, and critically migration and invasion of human ovarian cancer cells SKOV3 and A2780. Strikingly, OXT inhibited ovarian cancer metastasis by repressing the expressions of MMP-2 and VEGF. Moreover, OXT inhibited vascular endothelial cell tube formation by reducing the VEGF production from ovarian cancer cells. Our findings may provide a possible explanation for breastfeeding-associated protective effects and suggest new therapeutic opportunities for ovarian cancer. |
format | Online Article Text |
id | pubmed-5929082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-59290822018-05-02 Oxytocin inhibits ovarian cancer metastasis by repressing the expression of MMP-2 and VEGF Ji, Haoyi Liu, Na Yin, Yingchun Wang, Xinmei Chen, Xiaoyang Li, Jing Li, Jingxin J Cancer Research Paper Breastfeeding is associated with a decreased risk of ovarian cancer. However, the mechanism underlying this apparent clinical benefit is unknown. Oxytocin (OXT), a hypothalamic nonapetide, plays a crucial role in many reproductive and behavioural functions. In recent year, OXT acts as a growth regulator in many kind of tumor tissues, through the activation of a specific G-coupled transmembrane receptor, the oxytocin receptor (OXTR). OXT has been proved to inhibit the proliferation, migration and invasion of ovarian cancer SKOV3 cells in vitro. But, the underlying mechanisms remain unknown. Here, we found OXT inhibited proliferation, and critically migration and invasion of human ovarian cancer cells SKOV3 and A2780. Strikingly, OXT inhibited ovarian cancer metastasis by repressing the expressions of MMP-2 and VEGF. Moreover, OXT inhibited vascular endothelial cell tube formation by reducing the VEGF production from ovarian cancer cells. Our findings may provide a possible explanation for breastfeeding-associated protective effects and suggest new therapeutic opportunities for ovarian cancer. Ivyspring International Publisher 2018-04-06 /pmc/articles/PMC5929082/ /pubmed/29721047 http://dx.doi.org/10.7150/jca.23769 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Ji, Haoyi Liu, Na Yin, Yingchun Wang, Xinmei Chen, Xiaoyang Li, Jing Li, Jingxin Oxytocin inhibits ovarian cancer metastasis by repressing the expression of MMP-2 and VEGF |
title | Oxytocin inhibits ovarian cancer metastasis by repressing the expression of MMP-2 and VEGF |
title_full | Oxytocin inhibits ovarian cancer metastasis by repressing the expression of MMP-2 and VEGF |
title_fullStr | Oxytocin inhibits ovarian cancer metastasis by repressing the expression of MMP-2 and VEGF |
title_full_unstemmed | Oxytocin inhibits ovarian cancer metastasis by repressing the expression of MMP-2 and VEGF |
title_short | Oxytocin inhibits ovarian cancer metastasis by repressing the expression of MMP-2 and VEGF |
title_sort | oxytocin inhibits ovarian cancer metastasis by repressing the expression of mmp-2 and vegf |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929082/ https://www.ncbi.nlm.nih.gov/pubmed/29721047 http://dx.doi.org/10.7150/jca.23769 |
work_keys_str_mv | AT jihaoyi oxytocininhibitsovariancancermetastasisbyrepressingtheexpressionofmmp2andvegf AT liuna oxytocininhibitsovariancancermetastasisbyrepressingtheexpressionofmmp2andvegf AT yinyingchun oxytocininhibitsovariancancermetastasisbyrepressingtheexpressionofmmp2andvegf AT wangxinmei oxytocininhibitsovariancancermetastasisbyrepressingtheexpressionofmmp2andvegf AT chenxiaoyang oxytocininhibitsovariancancermetastasisbyrepressingtheexpressionofmmp2andvegf AT lijing oxytocininhibitsovariancancermetastasisbyrepressingtheexpressionofmmp2andvegf AT lijingxin oxytocininhibitsovariancancermetastasisbyrepressingtheexpressionofmmp2andvegf |